These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 26793823)

  • 1. Encouraging Maternal Sacrifice: How Regulations Governing the Consumption of Pharmaceuticals During Pregnancy Prioritize Fetal Safety over Maternal Health and Autonomy.
    Donley G
    Rev Law Soc Change; 2014-2015; 39(1):45-88. PubMed ID: 26793823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of Food and Drug Administration--approved medications for unlabeled (off-label) uses. The legal and ethical implications.
    Torres A
    Arch Dermatol; 1994 Jan; 130(1):32-6. PubMed ID: 8285737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDA drug labeling for pregnancy and lactation drug safety monitoring systems.
    Greene MF
    Semin Perinatol; 2015 Nov; 39(7):520-3. PubMed ID: 26428020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shared vulnerabilities in research.
    Chwang E
    Am J Bioeth; 2014; 14(12):3-11. PubMed ID: 25369404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new threat to pregnant women's autonomy.
    Johnsen D
    Hastings Cent Rep; 1987; 17(4):33-40. PubMed ID: 3667248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Including Pregnant Women in Clinical Research: Practical Guidance for Institutional Review Boards.
    Payne P
    Ethics Hum Res; 2019 Nov; 41(6):35-40. PubMed ID: 31743630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Balancing risks: making decisions for maternal treatment without data on fetal safety.
    Minkoff H; Ecker J
    Am J Obstet Gynecol; 2021 May; 224(5):479-483. PubMed ID: 33539824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pediatric drug development: ICH harmonized tripartite guideline E11 within the United States of America, the European Union, and Japan].
    Pflieger M; Bertram D
    Arch Pediatr; 2014 Oct; 21(10):1129-38. PubMed ID: 25175054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription of hazardous drugs during pregnancy.
    Malm H; Martikainen J; Klaukka T; Neuvonen PJ
    Drug Saf; 2004; 27(12):899-908. PubMed ID: 15366977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effects of the 12th and 14th amendments to the AMG (Medical Preparations Act) on paediatric pharmaceutical research--a survey of the new regulations].
    Kölch M; Lippert HD; Fegert JM
    Z Kinder Jugendpsychiatr Psychother; 2006 Mar; 34(2):117-26. PubMed ID: 16610597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research with pregnant women and fetuses: update on the ethics and the law.
    Hall JK
    J Nurs Law; 2000 Nov; 7(3):7-17. PubMed ID: 12848177
    [No Abstract]   [Full Text] [Related]  

  • 12. The ethics and regulatory landscape of including vulnerable populations in pragmatic clinical trials.
    Welch MJ; Lally R; Miller JE; Pittman S; Brodsky L; Caplan AL; Uhlenbrauck G; Louzao DM; Fischer JH; Wilfond B
    Clin Trials; 2015 Oct; 12(5):503-10. PubMed ID: 26374681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supplemental applications proposing labeling changes for approved drugs, biologics, and medical devices. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Aug; 73(164):49603-10. PubMed ID: 18958946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The new FDA pregnancy labeling requirements for drugs.
    Frederiksen MC
    J Midwifery Womens Health; 2011; 56(3):303-7. PubMed ID: 21535377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enrolling pregnant women: issues in clinical research.
    Blehar MC; Spong C; Grady C; Goldkind SF; Sahin L; Clayton JA
    Womens Health Issues; 2013 Jan; 23(1):e39-45. PubMed ID: 23312713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal Risks, Relative Risks, and Relatives' Risks.
    Minkoff H; Marshall MF
    Am J Bioeth; 2016; 16(2):3-11. PubMed ID: 26832079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethical issues and addiction.
    Lambert B; Scheiner M; Campbell D
    J Addict Dis; 2010 Apr; 29(2):164-74. PubMed ID: 20407974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2014 Dec; 79(233):72063-103. PubMed ID: 25509060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical ethics and maternal-fetal conflicts.
    Drane JF
    Pa Med; 1992 Jul; 95(7):12-6. PubMed ID: 1408260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent changes in pregnancy and lactation labeling: retirement of risk categories.
    Ramoz LL; Patel-Shori NM
    Pharmacotherapy; 2014; 34(4):389-95. PubMed ID: 24390829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.